Lamictal and Post procedural infection - a phase IV clinical study of FDA data

Summary:

Post procedural infection is reported as a side effect among people who take Lamictal (lamotrigine), especially for people who are female, 50-59 old, also take Vitamin D3, and have High blood pressure.

The phase IV clinical study analyzes which people have Post procedural infection when taking Lamictal. It is created by eHealthMe based on reports of 74,218 people who have side effects when taking Lamictal from the FDA, and is updated regularly.

What is Lamictal?

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 82,626 Lamictal users. Check the latest studies of Lamictal.

What is Post procedural infection?

Post procedural infection is found to be associated with 582 drugs and 564 conditions by eHealthMe. Check the latest studies of Post procedural infection.

On Jul, 10, 2026

74,218 people reported to have side effects when taking Lamictal.
Among them, 21 people (0.03%) have Post procedural infection.

Could Lamictal cause Post procedural infection?

Among these 21 people:

What is the gender of people who have Post procedural infection when taking Lamictal? *

female: 94.44 %
male: 5.56 %

What is the age of people who have Post procedural infection when taking Lamictal? *

What are other drugs people take besides Lamictal? *

What are other side effects people have besides Post procedural infection? *

Pain: 7 people, 33.33%
Joint Pain: 5 people, 23.81%
Fever: 4 people, 19.05%
Hypotension (abnormally low blood pressure): 4 people, 19.05%
Drowsiness: 3 people, 14.29%
Rectal Prolapse (falling of rectum from normal place): 3 people, 14.29%
Localised Infection (infection at the single location): 3 people, 14.29%
Confusional State: 3 people, 14.29%
Limb Injury: 3 people, 14.29%
Depression: 3 people, 14.29%

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 33.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 23.81%
Stress And Anxiety: 3 people, 14.29%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 14.29%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 9.52%
Astrocytoma, Low Grade (low grade tumour of the brain that originate in a particular kind of glial-cells): 2 people, 9.52%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 9.52%
Depression: 2 people, 9.52%
Fatigue (feeling of tiredness): 2 people, 9.52%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Lamictal and have Post procedural infection?

- Check whether Post procedural infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamictal:

Lamictal (82,626 reports)

Browse all side effects of Lamictal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural infection:

Post procedural infection (582 drugs)

Browse all the conditions that are associated with Post procedural infection:

Post procedural infection (564 conditions)

Related publications that referenced our studies

Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamictal) and Lamictal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.